SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2126619

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2126619

Heart Transplant Market, By Transplant Type, By Donor Type, By Indication, By End User, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Heart Transplant Market is estimated to be valued at USD 14.12 Bn in 2026 and is expected to reach USD 28.65 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 14.12 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.60% 2033 Value Projection: USD 28.65 Bn

The global heart transplant market is an important part of cardiovascular medicine that includes medical devices, immunosuppressive drugs, organ preservation solutions and post-transplant care products for patients with end-stage heart failure. Heart transplantation continues to be a mainstay of treatment for severe refractory heart failure that is unresponsive to conventional therapies. Improved patient outcomes have resulted from advances in surgical techniques, organ preservation, and immunosuppression.

The global heart transplant market growth is attributed to the increasing burden of cardiovascular diseases such as ischemic heart disease and cardiomyopathies, increasing transplant infrastructure, and development of organ donation and allocation system. Increasing clinical awareness, increasing healthcare expenditure and technological advancements in preservation and monitoring technologies are further bolstering the adoption of heart transplantation in developed and emerging markets.

Market Dynamics

The global heart transplant market is driven by rising burden of end-stage heart failure associated with cardiovascular diseases, diabetes, obesity, and hypertension. The advent of mechanical circulatory support devices such as left ventricular assist devices (LVADs), normothermic organ perfusion and better preservation technologies are helping in the management of patients and increasing the availability of transplantable hearts. Growing investments in transplant infrastructure, organ donation, and transplant registries in developed as well as emerging markets are also driving market growth.

However, the growth of heart transplant market is limited by factors such as persistent shortage of donor hearts, high transplantation and lifelong post-operative care costs, and complications such as organ rejection and infections. Nevertheless, xenotransplantation, bioengineered heart technologies, and growing transplant capabilities in Asia Pacific, Latin America and the Middle East present significant opportunities to overcome organ shortages and expand access to sophisticated heart failure treatment.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global heart transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include TransMedics Group, Inc., XVIVO, Getinge AB, Terumo Corporation, Bridge to Life Ltd., Organ Recovery Systems, Inc., Paragonix Technologies, Inc., Preservation Solutions, Inc., Global Transplant Solutions, Inc., and LivaNova PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global heart transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart transplant market

Market Segmentation

  • Transplant Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Orthotopic Heart Transplant
  • Heterotopic Heart Transplant
  • Donor Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Donation After Brain Death (DBD)
  • Donation After Circulatory Death (DCD)
  • Indication Insights (Revenue, USD Bn, 2021 - 2033)
  • End-Stage Heart Failure
  • Cardiomyopathy
  • Congenital Heart Disease
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialized Cardiac Transplant Centers
  • Academic and Research Institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • TransMedics Group, Inc.
  • XVIVO
  • Getinge AB
  • Terumo Corporation
  • Bridge to Life Ltd.
  • Organ Recovery Systems, Inc.
  • Paragonix Technologies, Inc.
  • Preservation Solutions, Inc.
  • Global Transplant Solutions, Inc.
  • LivaNova PLC
Product Code: CMI9945

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Heart Transplant Market, By Transplant Type
    • Global Heart Transplant Market, By Donor Type
    • Global Heart Transplant Market, By Indication
    • Global Heart Transplant Market, By End User
    • Global Heart Transplant Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Heart Transplant Market, By Transplant Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Orthotopic Heart Transplant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Heterotopic Heart Transplant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Heart Transplant Market, By Donor Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Donation After Brain Death (DBD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Donation After Circulatory Death (DCD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Heart Transplant Market, By Indication, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • End-Stage Heart Failure
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cardiomyopathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Congenital Heart Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Heart Transplant Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Specialized Cardiac Transplant Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Heart Transplant Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Company Profile
    • TransMedics Group, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • XVIVO
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Getinge AB
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bridge to Life Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Organ Recovery Systems, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Paragonix Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Preservation Solutions, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Global Transplant Solutions, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LivaNova PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!